SAN DIEGO, April 22, 2018 /PRNewswire/ -- Shareholder Rights
Law Firm Johnson Fistel, LLP is investigating potential claims
against FAT Brands Inc., Solid Biosciences Inc., and Grupo Televisa
S.A.B., as detailed below:
FAT Brands Inc.
On or about October 23, 2017, FAT
Brands Inc., (NASDAQ: FAT) ("Fat Brands") completed the Company's
initial public offering. The Company successfully raised
$12 Million through the sale of
2,000,000 of its shares to the public at $12.00 per share. However, since the IPO,
Fat Brands stock has imploded, on April 20,
2018, the stock closed at $6.32.
Specifically, Johnson Fistel's
investigation seeks to determine whether Fat Brands filings with
the U.S. Securities and Exchange Commission related to recent stock
offerings contained untrue statements of material facts or omitted
to state other facts necessary to make the statements made therein
not misleading.
If you have information that could assist in this
investigation, including former employees and others, or if you
purchased Fat Brands shares in the IPO and are interested in
learning more about the investigation or your legal rights and
remedies, please contact Jim Baker
(jimb@johnsonfistel.com) by email or by phone at
619-814-4471. If you email, please include your phone
number.
Solid Biosciences Inc.
Shareholder Rights Law Firm Johnson Fistel, LLP reminds
investors that a class action lawsuit has been filed against Solid
Biosciences Inc. (''Solid Biosciences '' or the ''Company'')
(NasdaqGS: SLDB) and certain of its officers, on behalf of
shareholders who purchased Solid Biosciences securities (1) in
Solid Biosciences 's initial public offering on or about
January 25, 2018; or (2) on the open
market from January 25, 2018 through
March 14, 2018, inclusive (the
''Class Period'').
On or about January 26, 2018,
Solid Biosciences completed the Company's initial public offering.
The Company successfully raised $125
Million through the sale of 7,812,500 of its shares to the
public at $16.00 per
share. However, since the IPO, Solid Biosciences stock has
imploded, on April 20, 2018, the
stock closed at $12.48, after
reaching $33.74 on March 2, 2018.
The complaint alleges that throughout the Class Period,
defendants made materially false and misleading statements and/or
failed to disclose that: (1) Solid's lead drug candidate, SGT-001,
had a high likelihood of causing adverse events in patients; (2)
The company misled investors regarding the toxicity of SGT-001; and
(3) consequently, defendants' statements in the Registration
Statement regarding Solid Biosciences' business, operations, and
prospects were materially false and/or misleading.
If you wish to serve as a lead plaintiff, you must move the
Court no later than May 29,
2018. If you wish to discuss this action, have any questions
concerning this notice, or your rights or interests, please contact
lead analyst Jim Baker
(jimb@johnsonfistel.com) at 619-814-4471. If you email, please
include your phone number.
Grupo Televisa, S.A.B.
Shareholder Rights Law Firm Johnson Fistel, LLP announces that a
class action lawsuit has commenced on behalf of persons or entities
who purchased or otherwise acquired securities of Grupo Televisa
S.A.B. (NYSE: TV) from April 11, 2013
through January 25, 2018, inclusive
(the "Class Period").
According to the lawsuit, defendants made materially false
misleading statements and failed to disclose that: (1) Grupo
Televisa executives engaged in an unlawful bribery scheme involving
Fédération Internationale de Football Association ("FIFA")
executives; (2) discovery of the foregoing conduct would likely
subject Grupo Televisa to heightened regulatory scrutiny; and (3)
Grupo Televisa lacked effective internal controls over financial
reporting. When the true details entered the market, the lawsuit
claims that investors suffered damages.
If you wish to serve as lead plaintiff, you must move the
Court no later than May 4,
2018. If you wish to discuss this action, have
any questions concerning this notice, or your rights or interests,
please contact lead analyst Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If
you email, please include your phone number.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York, and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonfistel.com. Attorney advertising. Past results do
not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
View original
content:http://www.prnewswire.com/news-releases/johnson-fistel-announces-investigations-of-fat-brands-inc-solid-biosciences-inc-and-grupo-televisa-sab-investors-with-losses-encouraged-to-contact-firm-300634159.html
SOURCE Johnson Fistel, LLP